The FDA recently approved a new version of Medtronic’s continuous glucose monitoring (CGM) system: the iPro2. The upgraded device is easier to use, collects more data, and does not need to be hooked up to a computer.
This entry was posted in News. Bookmark the permalink. Both comments and trackbacks are currently closed.
Medtronic Debuts New CGM Device
The FDA recently approved a new version of Medtronic’s continuous glucose monitoring (CGM) system: the iPro2. The upgraded device is easier to use, collects more data, and does not need to be hooked up to a computer.